肺大内分泌素会影响冠状动脉音调,导致在早期内分泌功能障碍时增强,ET(A) 介导的冠状动脉收缩
K Stangl1, T Dschietzig, M Laule
1Medizinische Klinik und Poliklinik I, Charité, Humboldt-Universität zu Berlin, Germany. stangl@rz.charite.hu-berlin.de
Circulation
|December 31, 1997
概括
肺中介剂,特别是内甲素 (ET),影响冠状动脉音调和血液流动. 来自肺部的大型ET转化为心脏中的ET,导致收缩,特别是在内皮功能障碍期间.
科学领域:
- 心血管生理学心血管生理学
- 肺部医学 肺部医学
- 内皮细胞功能 内皮细胞功能
背景情况:
- 肺中介剂对冠状动脉调节和心肌收缩性的影响尚不清楚.
- 开发了一种新的子肺心模型来研究这些影响.
研究的目的:
- 检查肺中介剂对冠状动脉度的影响.
- 在正常和早期内皮功能障碍条件下评估这些影响.
主要方法:
- 使用子肺心模型,使用肺排水对冠状动脉进行连续 perfusion.
- 使用的药理学药剂包括内甲素 (ET) 反对剂和ET转化酶抑制剂.
- 在肺部和冠状动脉废水中测量了冠状动脉流量和内甲蛋白水平.
主要成果:
- 与对照组相比,瓦塔纳贝子显示出内皮功能障碍和冠状动脉流量减少的证据.
- 冠状动脉流量下降被内甲素抗剂 (PD-145065,BQ-123,A-127722) 和光胺减轻.
- 肺部废水中存在大内素,在冠状动脉废水中转化为内素,特别是在瓦塔纳贝子中.
结论:
- 肺部的大内甲林在心脏内转化为内甲林.
- 这种局部转换导致ET(A) 介导的冠状动脉收缩.
- 这种收缩在早期内皮功能障碍存在时会加剧.
相关概念视频
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
Mitral Stenosis I: Introduction
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Atelectasis II: Pathophysiology
Atelectasis develops when alveoli lose their air and collapse inward. Because lung tissue is naturally elastic, these air sacs shrink rather than remaining open. Collapsed alveoli are no longer ventilated, reducing their role in gas exchange. Blood flow may continue in these regions, creating a ventilation–perfusion mismatch. Clinical findings include decreased breath sounds, dullness to percussion, reduced chest expansion, and decreased tactile fremitus as sound transmission through collapsed...
Chronic Obstructive Pulmonary Disease II: Emphysema
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
Pulmonary Edema II: Pathophysiology
Pulmonary edema is the accumulation of fluid in the interstitial and alveolar spaces of the lungs, impairing gas exchange and oxygen delivery. It may be cardiogenic or noncardiogenic, but both reduce oxygenation and lung compliance.Cardiogenic Pulmonary EdemaCardiogenic edema results from increased hydrostatic pressure in pulmonary capillaries, usually due to left ventricular dysfunction from myocardial infarction, heart failure, or valvular disease. Ineffective cardiac pumping causes blood to...


